{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T03:10:35Z","timestamp":1791429035856,"version":"4.3.3"},"reference-count":89,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,25]],"date-time":"2024-11-25T00:00:00Z","timestamp":1732492800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,11,25]],"date-time":"2024-11-25T00:00:00Z","timestamp":1732492800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurogenetics"],"DOI":"10.1007\/s10048-024-00794-4","type":"journal-article","created":{"date-parts":[[2024,11,25]],"date-time":"2024-11-25T02:25:28Z","timestamp":1732501528000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Understanding pathophysiology in fragile X syndrome: a comprehensive review"],"prefix":"10.1007","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7107-1370","authenticated-orcid":false,"given":"Juan Carlos Castillo","family":"Ju\u00e1rez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-1608-6563","authenticated-orcid":false,"given":"Alejandro Aguilar","family":"G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-3043-5886","authenticated-orcid":false,"given":"Adrian Esteban Salatino","family":"D\u00edaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel Silva","family":"Ar\u00e9valo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,25]]},"reference":[{"key":"794_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/nrdp.2017.65","volume":"3","author":"RJ Hagerman","year":"2017","unstructured":"Hagerman RJ, Berry-Kravis E, Hazlett HC, Bailey DB Jr, Moine H, Kooy RF et al (2017) Fragile X syndrome. Nat Rev Dis Prim 3:1\u201319. https:\/\/doi.org\/10.1038\/nrdp.2017.65","journal-title":"Nat Rev Dis Prim"},{"issue":"1","key":"794_CR2","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s13052-017-0355-y","volume":"43","author":"C Ciaccio","year":"2017","unstructured":"Ciaccio C, Fontana L, Milani D, Tabano S, Miozzo M, Esposito S (2017) Fragile X syndrome: a review of clinical and molecular diagnoses. Ital J Pediatr 43(1):39. https:\/\/doi.org\/10.1186\/s13052-017-0355-y","journal-title":"Ital J Pediatr"},{"issue":"1","key":"794_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-019-50240-x","volume":"9","author":"AK Simhal","year":"2019","unstructured":"Simhal AK, Zuo Y, Perez MM, Madison DV, Sapiro G, Micheva KD (2019) Multifaceted changes in synaptic composition and astrocytic involvement in a mouse model of Fragile X Syndrome. Sci Rep 9(1):1\u201316. https:\/\/doi.org\/10.1038\/s41598-019-50240-x","journal-title":"Sci Rep"},{"issue":"1","key":"794_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-018-30025-4","volume":"8","author":"N Sunamura","year":"2018","unstructured":"Sunamura N, Iwashita S, Enomoto K, Kadoshima T, Isono F (2018) Loss of the fragile X mental retardation protein causes aberrant differentiation in human neural progenitor cells. Sci Rep 8(1):1\u201313. https:\/\/doi.org\/10.1038\/s41598-018-30025-4","journal-title":"Sci Rep"},{"issue":"7","key":"794_CR5","doi-asserted-by":"publisher","first-page":"1648","DOI":"10.1002\/ajmg.a.36511","volume":"164A","author":"J Hunter","year":"2014","unstructured":"Hunter J, Rivero-Arias O, Angelov A, Kim E, Fotheringham I, Leal J (2014) Epidemiology of fragile X syndrome: a systematic review and meta-analysis. Am J Med Genet A 164A(7):1648\u20131658","journal-title":"Am J Med Genet A"},{"key":"794_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fneur.2017.00254","volume":"8","author":"M Niu","year":"2017","unstructured":"Niu M, Han Y, Dy ABC, Du J, Jin H, Qin J et al (2017) Fragile X syndrome: prevalence, treatment, and Prevention in China. Front Neurol 8:1\u20137. https:\/\/doi.org\/10.3389\/fneur.2017.00254","journal-title":"Front Neurol"},{"issue":"4","key":"794_CR7","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1038\/s10038-017-0407-6","volume":"63","author":"W Saldarriaga","year":"2018","unstructured":"Saldarriaga W, Forero-Forero JV, Gonz\u00e1lez-Teshima LY, Fandi\u00f1o-Losada A, Isaza C, Tovar-Cuevas JR et al (2018) Genetic cluster of Fragile X syndrome in a Colombian district. J Hum Genet 63(4):509\u2013516","journal-title":"J Hum Genet"},{"issue":"4","key":"794_CR8","doi-asserted-by":"publisher","first-page":"190","DOI":"10.25100\/cm.v45i4.1810","volume":"45","author":"W Saldarriaga","year":"2014","unstructured":"Saldarriaga W, Tassone F, Gonz\u00e1lez-Teshima LY, Forero-Forero JV, Ayala-Zapata S, Hagerman R (2014) Fragile X syndrome. Colomb Med (Cali) 45(4):190\u2013198. https:\/\/colombiamedica.univalle.edu.co\/index.php\/comedica\/article\/view\/1810","journal-title":"Colomb Med (Cali)"},{"issue":"10","key":"794_CR9","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/j.tig.2017.07.008","volume":"33","author":"JK Davis","year":"2017","unstructured":"Davis JK, Broadie K (2017) Multifarious functions of the Fragile X Mental retardation protein. Trends Genet 33(10):703\u2013714. https:\/\/doi.org\/10.1016\/j.tig.2017.07.008","journal-title":"Trends Genet"},{"key":"794_CR10","doi-asserted-by":"publisher","first-page":"104740","DOI":"10.1016\/j.nbd.2020.104740","volume":"136","author":"MJ Salcedo-Arellano","year":"2020","unstructured":"Salcedo-Arellano MJ, Dufour B, McLennan Y, Martinez-Cerdeno V, Hagerman R (2020) Fragile X syndrome and associated disorders: clinical aspects and pathology. Neurobiol Dis 136:104740. https:\/\/doi.org\/10.1016\/j.nbd.2020.104740","journal-title":"Neurobiol Dis"},{"key":"794_CR11","doi-asserted-by":"crossref","unstructured":"Hagerman RJ, Protic D, Rajaratnam A, Salcedo-Arellano MJ, Aydin EY, Schneider A (2018) Fragile X-Associated Neuropsychiatric Disorders (FXAND). Front Psychiatry 9:564. fe","DOI":"10.3389\/fpsyt.2018.00564"},{"key":"794_CR12","doi-asserted-by":"publisher","unstructured":"Mbachu CNP, Mbachu II, Hagerman R (2024) A Comprehensive Review of Fragile X Syndrome and Fragile X Premutation Associated conditions in Africa. Genes (Basel) 15(6). https:\/\/doi.org\/10.3390\/genes15060683","DOI":"10.3390\/genes15060683"},{"key":"794_CR13","doi-asserted-by":"publisher","first-page":"208","DOI":"10.7916\/D80V89FC","volume":"4","author":"DA Hall","year":"2014","unstructured":"Hall DA (2014) In the Gray Zone in the Fragile X Gene: what are the key unanswered clinical and biological questions? Tremor Other Hyperkinetic Mov. (N Y) 4:208. https:\/\/doi.org\/10.7916\/D80V89FC","journal-title":"(N Y)"},{"issue":"8","key":"794_CR14","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1002\/mds.28086","volume":"35","author":"DA Hall","year":"2020","unstructured":"Hall DA, Nag S, Ouyang B, Bennett DA, Liu Y, Ali A et al (2020) Fragile X Gray Zone alleles are Associated with signs of parkinsonism and earlier death. Mov Disord 35(8):1448\u20131456. https:\/\/doi.org\/10.1002\/mds.28086","journal-title":"Mov Disord"},{"issue":"1","key":"794_CR15","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1002\/mrdd.20004","volume":"10","author":"D Hessl","year":"2004","unstructured":"Hessl D, Rivera SM, Reiss AL (2004) The neuroanatomy and neuroendocrinology of fragile X syndrome. Ment Retard Dev Disabil Res Rev 10(1):17\u201324. https:\/\/doi.org\/10.1002\/mrdd.20004","journal-title":"Ment Retard Dev Disabil Res Rev"},{"issue":"3","key":"794_CR16","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1038\/npp.2013.257","volume":"39","author":"I Ivanov","year":"2014","unstructured":"Ivanov I, Murrough JW, Bansal R, Hao X, Peterson BS (2014) Cerebellar morphology and the effects of stimulant medications in youths with attention deficit-hyperactivity disorder. Neuropsychopharmacology 39(3):718\u2013726","journal-title":"Neuropsychopharmacology"},{"key":"794_CR17","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1002\/ana.21243","volume":"63","author":"D Gothelf","year":"2008","unstructured":"Gothelf D, Furfaro JA, Hoeft F, Eckert MA, Hall SS, O\u2019Hara R et al (2008) Neuroanatomy of Fragile X syndrome is Associated with aberrant behavior and the Fragile X Mental retardation protein (FMRP). Ann Neurol 63:40\u201351. https:\/\/doi.org\/10.1002\/ana.21243","journal-title":"Ann Neurol"},{"issue":"3","key":"794_CR18","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1055\/s-0034-1386764","volume":"34","author":"TW Yu","year":"2014","unstructured":"Yu TW, Berry-Kravis E (2014) Autism and fragile X syndrome. Semin Neurol 34(3):258\u2013265. https:\/\/doi.org\/10.1055\/s-0034-1386764","journal-title":"Semin Neurol"},{"issue":"2","key":"794_CR19","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/s12311-014-0627-7","volume":"14","author":"O Baumann","year":"2015","unstructured":"Baumann O, Borra RJ, Bower JM, Cullen KE, Habas C, Ivry RB et al (2015) Consensus paper: the role of the cerebellum in perceptual processes. Cerebellum 14(2):197\u2013220. https:\/\/doi.org\/10.1007\/s12311-014-0627-7","journal-title":"Cerebellum"},{"issue":"1","key":"794_CR20","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s13395-017-0136-8","volume":"7","author":"R Fujita","year":"2017","unstructured":"Fujita R, Zismanov V, Jacob J-M, Jamet S, Asiev K, Crist C (2017) Fragile X mental retardation protein regulates skeletal muscle stem cell activity by regulating the stability of Myf5 mRNA. Skelet Muscle 7(1):18. https:\/\/doi.org\/10.1186\/s13395-017-0136-8","journal-title":"Skelet Muscle"},{"key":"794_CR21","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.neubiorev.2016.06.033","volume":"68","author":"C Bostrom","year":"2016","unstructured":"Bostrom C, Yau S, Majaess N, Ventrici M, Gil-Mohapel J, Christie B (2016) Hippocampal dysfunction and cognitive impairment in Fragile-X syndrome. Neurosci Biobehav Rev 68:563\u2013574. https:\/\/doi.org\/10.1016\/j.neubiorev.2016.06.033","journal-title":"Neurosci Biobehav Rev"},{"key":"794_CR22","doi-asserted-by":"publisher","unstructured":"Yau S, Li A, So KF (2015) Involvement of Adult Hippocampal Neurogenesis in Learning and Forgetting. Neural Plast 2015:1\u201313. https:\/\/doi.org\/10.1155\/2015\/717958","DOI":"10.1155\/2015\/717958"},{"issue":"4","key":"794_CR23","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1002\/cne.24100","volume":"525","author":"D Zorio","year":"2017","unstructured":"Zorio D, Jackson CM, Liu Y, Rubel EW, Wang Y (2017) Cellular distribution of Fragile X Mental retardation protein in the mouse brain. J Comp Neurol 525(4):818\u2013849. https:\/\/doi.org\/10.1002\/cne.24100","journal-title":"J Comp Neurol"},{"issue":"1","key":"794_CR24","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1002\/ca.22781","volume":"30","author":"P Oakes","year":"2017","unstructured":"Oakes P, Loukas M, Oskouian RJ, Tubbs RS (2017) The neuroanatomy of depression: a review. Clin Anat 30(1):44\u201349. https:\/\/doi.org\/10.1002\/ca.22781","journal-title":"Clin Anat"},{"key":"794_CR25","unstructured":"Jawabri K, Sharma S (2021) Physiology, Cerebral Cortex Functions. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK538496\/"},{"key":"794_CR26","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.intell.2015.04.009","volume":"51","author":"U Basten","year":"2015","unstructured":"Basten U, Hilger K, Fiebach CJ (2015) Where smart brains are different: a quantitative meta-analysis of functional and structural brain imaging studies on intelligence. Intelligence 51:10\u201327. https:\/\/doi.org\/10.1016\/j.intell.2015.04.009","journal-title":"Intelligence"},{"issue":"5","key":"794_CR27","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1159\/000329424","volume":"33","author":"JL Olmos-Serrano","year":"2011","unstructured":"Olmos-Serrano JL, Corbin JG (2011) Amygdala regulation of fear and emotionality in Fragile X Syndrome. Dev Neurosci 33(5):365\u2013378. https:\/\/doi.org\/10.1159\/000329424","journal-title":"Dev Neurosci"},{"issue":"5","key":"794_CR28","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1542\/peds.2013-4301","volume":"134","author":"SA Kidd","year":"2014","unstructured":"Kidd SA, Lachiewicz A, Barbouth D, Blitz RK, Delahunty C, McBrien D et al (2014) Fragile X syndrome: a review of associated medical problems. Pediatrics 134(5):995\u20131005. https:\/\/doi.org\/10.1542\/peds.2013-4301","journal-title":"Pediatrics"},{"issue":"3","key":"794_CR29","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1016\/j.neuroimage.2006.09.043","volume":"34","author":"AD Lee","year":"2007","unstructured":"Lee AD, Leow AD, Lu A, Reiss AL, Hall S, Chiang M-C et al (2007) 3D pattern of brain abnormalities in Fragile X syndrome visualized using tensor-base morphometry. NeuroImage 34(3):924\u2013938. https:\/\/doi.org\/10.1016\/j.neuroimage.2006.09.043","journal-title":"NeuroImage"},{"issue":"1","key":"794_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bbr.2011.11.018","volume":"228","author":"S Veeraragavan","year":"2012","unstructured":"Veeraragavan S, Graham D, Bui N, Yuva-Paylor LA, Wess J, Paylor R (2012) Genetic reduction of muscarinic M4 receptor modulates analgesic response and acoustic startle response in a mouse model of fragile X syndrome (FXS). Behav Brain Res 228(1):1\u20138. https:\/\/doi.org\/10.1016\/j.bbr.2011.11.018","journal-title":"Behav Brain Res"},{"key":"794_CR31","doi-asserted-by":"publisher","first-page":"9318346","DOI":"10.1155\/2017\/9318346","volume":"2017","author":"C Charalsawadi","year":"2017","unstructured":"Charalsawadi C, Wirojanan J, Jaruratanasirikul S, Ruangdaraganon N, Geater A, Limprasert P (2017) Common clinical characteristics and Rare Medical problems of Fragile X Syndrome in Thai patients and Review of the literature. Int J Pediatr 2017:9318346. https:\/\/doi.org\/10.1155\/2017\/9318346","journal-title":"Int J Pediatr"},{"key":"794_CR32","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.seizure.2014.09.003","volume":"24","author":"C Cianchetti","year":"2015","unstructured":"Cianchetti C, Messina P, Pupillo E, Crichiutti G, Baglietto MG, Veggiotti P et al (2015) The perceived burden of epilepsy: impact on the quality of life of children and adolescents and their families. Seizure 24:93\u2013101. https:\/\/doi.org\/10.1016\/j.seizure.2014.09.003","journal-title":"Seizure"},{"issue":"12","key":"794_CR33","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1111\/jir.12215","volume":"59","author":"K Chevreul","year":"2015","unstructured":"Chevreul K, Berg Brigham K, Brunn M, des Portes V, Serrano-Aguilar P, Linertov\u00e1 R et al (2015) Fragile X syndrome: economic burden and health-related quality of life of patients and caregivers in France. J Intellect Disabil Res 59(12):1108\u20131120","journal-title":"J Intellect Disabil Res"},{"issue":"1","key":"794_CR34","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1542\/peds.2006-2697","volume":"119","author":"KR Ginsburg","year":"2007","unstructured":"Ginsburg KR (2007) The importance of play in promoting healthy child development and maintaining strong parent-child bonds. Pediatrics 119(1):182\u2013191. https:\/\/pediatrics.aappublications.org\/content\/119\/1\/182.abstract","journal-title":"Pediatrics"},{"key":"794_CR35","unstructured":"Merino Merino B, Gonz\u00e1lez Briones E (2006) Recomendaciones sobre Actividad F\u00edsica para la infancia y la adolescencia. Gu\u00eda para todas las personas que participan en su educaci\u00f3n. Salud P\u00fablica, Promoci\u00f3n de la Salud y Epidemiolog\u00eda, Espa\u00f1a, pp 23\u201328. https:\/\/www.mscbs.gob.es\/ciudadanos\/proteccionSalud\/adultos\/actiFisica\/docs\/ActividadFisicaSaludEspanol.pdf"},{"issue":"4","key":"794_CR36","doi-asserted-by":"publisher","first-page":"377","DOI":"10.5014\/ajot.59.4.377","volume":"59","author":"S Goldstand","year":"2005","unstructured":"Goldstand S, Koslowe KC, Parush S (2005) Vision, visual-information processing, and academic performance among seventh-grade schoolchildren: a more significant relationship than we thought? Am J Occup Ther 59(4):377\u2013389","journal-title":"Am J Occup Ther"},{"key":"794_CR37","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.neuroscience.2012.03.049","volume":"251","author":"CX He","year":"2013","unstructured":"He CX, Portera-Cailliau C (2013) The trouble with spines in fragile X syndrome: density, maturity and plasticity. Neuroscience 251:120\u2013128. https:\/\/doi.org\/10.1016\/j.neuroscience.2012.03.049","journal-title":"Neuroscience"},{"issue":"1","key":"794_CR38","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/2040-2392-2-2","volume":"2","author":"CM Greco","year":"2011","unstructured":"Greco CM, Navarro CS, Hunsaker MR, Maezawa I, Shuler JF, Tassone F et al (2011) Neuropathologic features in the hippocampus and cerebellum of three older men with fragile X syndrome. Mol Autism 2(1):2. https:\/\/doi.org\/10.1186\/2040-2392-2-2","journal-title":"Mol Autism"},{"issue":"4","key":"794_CR39","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1111\/j.1535-7511.2009.01309.x","volume":"9","author":"P Hagerman","year":"2009","unstructured":"Hagerman P, Stafstrom C (2009) Origins of epilepsy in fragile X syndrome. Epilepsy Curr 9(4):108\u2013112. https:\/\/doi.org\/10.1111\/j.1535-7511.2009.01309.x","journal-title":"Epilepsy Curr"},{"issue":"4","key":"794_CR40","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/j.neuron.2015.06.017","volume":"87","author":"A Contractor","year":"2015","unstructured":"Contractor A, Klyachko VA, Portera-Cailliau C (2015) Altered neuronal and circuit excitability in fragile X syndrome. Neuron 87(4):699\u2013715. https:\/\/doi.org\/10.1016\/j.neuron.2015.06.017","journal-title":"Neuron"},{"key":"794_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neubiorev.2014.01.006","volume":"46","author":"T Maurin","year":"2014","unstructured":"Maurin T, Zongaro S, Bardoni B (2014) Fragile X syndrome: from molecular pathology to therapy. Neurosci Biobehav Rev 46:1\u201314. https:\/\/doi.org\/10.1016\/j.neubiorev.2014.01.006","journal-title":"Neurosci Biobehav Rev"},{"key":"794_CR42","doi-asserted-by":"publisher","unstructured":"Nolze A, Schneider J, Keil R, Lederer M, H\u00fcttelmaier S, Kessels MM et al (2013) FMRP regulates actin filament organization via the armadillo protein p0071. RNA 19(11):1483\u201396. https:\/\/doi.org\/10.1261\/rna.037945.112","DOI":"10.1261\/rna.037945.112"},{"issue":"3","key":"794_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1113\/JP275571","volume":"596","author":"K Michaelsen-Preusse","year":"2018","unstructured":"Michaelsen-Preusse K, Feuge J, Korte M (2018) Imbalance of synaptic actin dynamics as a key to fragile X syndrome? J Physiol 596(3):1\u201310. https:\/\/doi.org\/10.1113\/JP275571","journal-title":"J Physiol"},{"key":"794_CR44","doi-asserted-by":"publisher","first-page":"60","DOI":"10.3389\/fnmol.2016.00060","volume":"9","author":"FJ Bodaleo","year":"2016","unstructured":"Bodaleo FJ, Gonzalez-Billault C (2016) The presynaptic microtubule cytoskeleton in physiological and pathological conditions: lessons from Drosophila Fragile X syndrome and hereditary spastic paraplegias. Front Mol Neurosci 9:60. https:\/\/doi.org\/10.3389\/fnmol.2016.00060","journal-title":"Front Mol Neurosci"},{"issue":"42","key":"794_CR45","doi-asserted-by":"publisher","first-page":"15201","DOI":"10.1073\/pnas.0404995101","volume":"101","author":"R Lu","year":"2004","unstructured":"Lu R, Wang H, Liang Z, Ku L, Donnell WTO, Li W et al (2004) The fragile X protein controls microtubule-associated protein 1B translation and microtubule stability in brain neuron development. PNAS 101(42):15201\u201315206. https:\/\/doi.org\/10.1073\/pnas.0404995101","journal-title":"PNAS"},{"key":"794_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2012\/197491","volume":"2012","author":"C Cheng","year":"2012","unstructured":"Cheng C, Sourial M, Doering LC (2012) Astrocytes and developmental plasticity in fragile X. Neural Plast 2012:1\u201312. https:\/\/doi.org\/10.1155\/2012\/197491","journal-title":"Neural Plast"},{"key":"794_CR47","doi-asserted-by":"publisher","unstructured":"Yang Q, Feng B, Zhang K, Guo Y, Liu S, Wu Y et al (2012) Excessive astrocyte-derived neurotrophin-3 contributes to the abnormal neuronal dendritic development in a mouse model of fragile X syndrome. PLoS Genet 8(12). https:\/\/doi.org\/10.1371\/journal.pgen.1003172","DOI":"10.1371\/journal.pgen.1003172"},{"issue":"1","key":"794_CR48","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s13041-016-0256-9","volume":"9","author":"C Cheng","year":"2016","unstructured":"Cheng C, Lau SKM, Doering LC (2016) Astrocyte-secreted thrombospondin-1 modulates synapse and spine defects in the fragile X mouse model. Mol Brain 9(1):74. https:\/\/doi.org\/10.1186\/s13041-016-0256-9","journal-title":"Mol Brain"},{"key":"794_CR49","doi-asserted-by":"publisher","first-page":"268","DOI":"10.3389\/fnmol.2017.00268","volume":"10","author":"J Wallingford","year":"2017","unstructured":"Wallingford J, Scott AL, Rodrigues K, Doering LC (2017) Altered developmental expression of the astrocyte-secreted factors Hevin and SPARC in the Fragile X Mouse Model. Front Mol Neurosci 10:268. https:\/\/doi.org\/10.3389\/fnmol.2017.00268","journal-title":"Front Mol Neurosci"},{"issue":"27","key":"794_CR50","doi-asserted-by":"publisher","first-page":"7079","DOI":"10.1523\/jneurosci.1069-16.2016","volume":"36","author":"H Higashimori","year":"2016","unstructured":"Higashimori H, Schin CS, Chiang MSR, Morel L, Shoneye TA, Nelson DL et al (2016) Selective deletion of astroglial FMRP dysregulates glutamate transporter GLT1 and contributes to fragile X syndrome phenotypes in vivo. J Neurosci 36(27):7079\u20137094. https:\/\/doi.org\/10.1523\/jneurosci.1069-16.2016","journal-title":"J Neurosci"},{"key":"794_CR51","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.mcn.2015.11.011","volume":"73","author":"A Bhattacharyya","year":"2016","unstructured":"Bhattacharyya A, Zhao X (2016) Human pluripotent stem cell models of Fragile X syndrome. Mol Cell Neurosci 73:43\u201351. https:\/\/doi.org\/10.1016\/j.mcn.2015.11.011","journal-title":"Mol Cell Neurosci"},{"issue":"19","key":"794_CR52","doi-asserted-by":"publisher","first-page":"3920","DOI":"10.1093\/hmg\/ddt246","volume":"22","author":"LKK Pacey","year":"2013","unstructured":"Pacey LKK, Xuan ICY, Guan S, Sussman D, Henkelman RM, Chen Y et al (2013) Delayed myelination in a mouse model of fragile X syndrome. Hum Mol Genet 22(19):3920\u20133930. https:\/\/doi.org\/10.1093\/hmg\/ddt246","journal-title":"Hum Mol Genet"},{"issue":"2","key":"794_CR53","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1002\/stem.2505","volume":"35","author":"O Khalfallah","year":"2017","unstructured":"Khalfallah O, Jarjat M, Davidovic L, Nottet N, Cestele S, Mantegazza M et al (2017) Depletion of the Fragile X Mental retardation protein in embryonic stem cells alters the kinetics of Neurogenesis. Stem Cells 35(2):374\u2013385. https:\/\/doi.org\/10.1002\/stem.2505","journal-title":"Stem Cells"},{"issue":"46","key":"794_CR54","doi-asserted-by":"publisher","first-page":"15295","DOI":"10.1523\/JNEUROSCI.0317-15.2015","volume":"35","author":"M Telias","year":"2015","unstructured":"Telias M, Kuznitsov-Yanovsky L, Segal M, Ben-Yosef D (2015) Functional deficiencies in fragile X neurons derived from human embryonic stem cells. J Neurosci 35(46):15295\u201315306. https:\/\/doi.org\/10.1523\/JNEUROSCI.0317-15.2015","journal-title":"J Neurosci"},{"issue":"4","key":"794_CR55","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1523\/JNEUROSCI.4854-10.2011","volume":"31","author":"R Saffary","year":"2011","unstructured":"Saffary R, Xie Z (2011) FMRP regulates the transition from radial glial cells to intermediate progenitor cells during neocortical development. J Neurosci 31(4):1427\u20131439. https:\/\/doi.org\/10.1523\/JNEUROSCI.4854-10.2011","journal-title":"J Neurosci"},{"issue":"2","key":"794_CR56","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.nbd.2008.10.010","volume":"33","author":"TA Tervonen","year":"2009","unstructured":"Tervonen TA, Louhivuori V, Sun X, Hokkanen M-E, Kratochwil CF, Zebryk P et al (2009) Aberrant differentiation of glutamatergic cells in neocortex of mouse model for fragile X syndrome. Neurobiol Dis 33(2):250\u2013259. https:\/\/doi.org\/10.1016\/j.nbd.2008.10.010","journal-title":"Neurobiol Dis"},{"issue":"1","key":"794_CR57","doi-asserted-by":"publisher","first-page":"103","DOI":"10.15173\/mumj.v17i1.2338","volume":"17","author":"ZJ Li","year":"2020","unstructured":"Li ZJ, Oliveria J (2020) The critical role of astrogenesis and neurodevelopment in Fragile X Syndrome and Rett Syndrome. MUMJ 17(1):103\u2013121. https:\/\/doi.org\/10.15173\/mumj.v17i1.2338","journal-title":"MUMJ"},{"issue":"20","key":"794_CR58","doi-asserted-by":"publisher","first-page":"2353","DOI":"10.1089\/scd.2015.0220","volume":"24","author":"M Telias","year":"2015","unstructured":"Telias M, Mayshar Y, Amit A, Ben-Yosef D (2015) Molecular mechanisms regulating impaired neurogenesis of fragile X syndrome human embryonic stem cells. Stem Cells Dev 24(20):2353\u20132365. https:\/\/doi.org\/10.1089\/scd.2015.0220","journal-title":"Stem Cells Dev"},{"issue":"2","key":"794_CR59","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.nbd.2010.10.018","volume":"41","author":"V Louhivuori","year":"2011","unstructured":"Louhivuori V, Vicario A, Uutela M, Rantamaki T, Louhivuori LM, Castren E et al (2011) BDNF and TrkB in neuronal differentiation of Fmr1-knockout mouse. Neurobiol Dis 41(2):469\u2013480. https:\/\/doi.org\/10.1016\/j.nbd.2010.10.018","journal-title":"Neurobiol Dis"},{"key":"794_CR60","doi-asserted-by":"publisher","first-page":"29","DOI":"10.3389\/fnmol.2017.00029","volume":"10","author":"CJ Westmark","year":"2017","unstructured":"Westmark CJ (2017) Commentary: depletion of the Fragile X Mental retardation protein in embryonic stem cells alters the kinetics of Neurogenesis. Front Mol Neurosci 10:29. https:\/\/doi.org\/10.3389\/fnmol.2017.00029","journal-title":"Front Mol Neurosci"},{"key":"794_CR61","doi-asserted-by":"publisher","unstructured":"Brighi C, Salaris F, Soloperto A, Cordella F, Ghirga S, Turris V, De et al (2021) Novel fragile X syndrome 2D and 3D brain models based on human isogenic FMRP-KO iPSCs. Cell Death Dis 12:498. https:\/\/doi.org\/10.1038\/s41419-021-03776-8","DOI":"10.1038\/s41419-021-03776-8"},{"key":"794_CR62","doi-asserted-by":"publisher","first-page":"160","DOI":"10.2741\/s455","volume":"8","author":"ML Castren","year":"2016","unstructured":"Castren ML (2016) Cortical neurogenesis in fragile X syndrome. Front Biosci 8:160\u2013168. https:\/\/www.fbscience.com\/Scholar\/articles\/pdf\/Scholar455.pdf","journal-title":"Front Biosci"},{"issue":"3","key":"794_CR63","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1083\/jcb.201607093","volume":"216","author":"RM O\u2019Connor","year":"2017","unstructured":"O\u2019Connor RM, Stone EF, Wayne CR, Marcinkevicius EV, Ulgherait M, Delventhal R et al (2017) A Drosophila model of Fragile X syndrome exhibits defects in phagocytosis by innate immune cells. J Cell Biol 216(3):595\u2013605. https:\/\/doi.org\/10.1083\/jcb.201607093","journal-title":"J Cell Biol"},{"issue":"18","key":"794_CR64","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1097\/WNR.0000000000000905","volume":"28","author":"SL Hodges","year":"2017","unstructured":"Hodges SL, Nolan SO, Taube JH, Lugo JN (2017) Adult Fmr1 knockout mice present with deficiencies in hippocampal interleukin-6 and tumor necrosis factor-alpha expression. NeuroReport 28(18):1246\u20131249. https:\/\/doi.org\/10.1097\/WNR.0000000000000905","journal-title":"NeuroReport"},{"issue":"1","key":"794_CR65","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1186\/s12883-020-01715-2","volume":"20","author":"A Van Dijck","year":"2020","unstructured":"Van Dijck A, Barbosa S, Bermudez-Martin P, Khalfallah O, Gilet C, Martinuzzi E et al (2020) Reduced serum levels of pro-inflammatory chemokines in fragile X syndrome. BMC Neurol 20(1):138. https:\/\/pubmed.ncbi.nlm.nih.gov\/32295518","journal-title":"BMC Neurol"},{"issue":"4","key":"794_CR66","doi-asserted-by":"publisher","first-page":"110","DOI":"10.5582\/irdr.2014.01027","volume":"3","author":"AC Hanson","year":"2014","unstructured":"Hanson AC, Hagerman RJ (2014) Serotonin dysregulation in Fragile X Syndrome: implications for treatment. Intractable Rare Dis Res 3(4):110\u2013117","journal-title":"Intractable Rare Dis Res"},{"issue":"4","key":"794_CR67","doi-asserted-by":"publisher","first-page":"251","DOI":"10.2174\/1573396315666190625110748","volume":"15","author":"D Protic","year":"2019","unstructured":"Protic D, Salcedo-Arellano MJ, Dy JB, Potter LA, Hagerman RJ (2019) New targeted treatments for fragile X syndrome. Curr Pediatr Rev 15(4):251\u2013258. https:\/\/pubmed.ncbi.nlm.nih.gov\/31241016","journal-title":"Curr Pediatr Rev"},{"key":"794_CR68","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.neubiorev.2015.03.023","volume":"55","author":"P Jaiswal","year":"2015","unstructured":"Jaiswal P, Mohanakumar KP, Rajamma U (2015) Serotonin mediated immunoregulation and neural functions: complicity in the aetiology of autism spectrum disorders. Neurosci Biobehav Rev 55:413\u2013431. https:\/\/doi.org\/10.1016\/j.neubiorev.2015.03.023","journal-title":"Neurosci Biobehav Rev"},{"key":"794_CR69","doi-asserted-by":"publisher","first-page":"3259","DOI":"10.1038\/ncomms4259","volume":"5","author":"Z Zhou","year":"2014","unstructured":"Zhou Z, Cao M, Guo Y, Zhao L, Wang J, Jia X et al (2014) Fragile X mental retardation protein stimulates ribonucleoprotein assembly of influenza a virus. Nat Commun 5:3259. https:\/\/doi.org\/10.1038\/ncomms4259","journal-title":"Nat Commun"},{"key":"794_CR70","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.virusres.2018.03.006","volume":"249","author":"M Muto","year":"2018","unstructured":"Muto M, Kamitani W, Sakai M, Hirano M, Kobayashi S, Kariwa H et al (2018) Identification and analysis of host proteins that interact with the 3\u2032-untranslated region of tick-borne encephalitis virus genomic RNA. Virus Res 249:52\u201356. https:\/\/doi.org\/10.1016\/j.virusres.2018.03.006","journal-title":"Virus Res"},{"key":"794_CR71","doi-asserted-by":"publisher","unstructured":"Zhan X, Pu J, Sun Y, Bi Y, Jiang Z, Xu G et al (2021) Neurovirulence of Avian Influenza Virus is dependent on the Interaction of viral NP Protein with FMRP in the murine brain. J Virol 95(7). https:\/\/doi.org\/10.1128\/jvi.01272-20","DOI":"10.1128\/jvi.01272-20"},{"issue":"1","key":"794_CR72","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.virol.2009.02.006","volume":"387","author":"Q Pan","year":"2009","unstructured":"Pan Q, Rong L, Zhao X, Liang C (2009) Fragile X mental retardation protein restricts replication of human immunodeficiency virus type 1. Virology 387(1):127\u2013135. https:\/\/doi.org\/10.1016\/j.virol.2009.02.006","journal-title":"Virology"},{"key":"794_CR73","doi-asserted-by":"crossref","unstructured":"Soto-Acosta R, Xie X, Shan C, Baker CK, Shi P-Y, Rossi SL et al (2018) Fragile X mental retardation protein is a Zika virus restriction factor that is antagonized by subgenomic flaviviral RNA. Elife 7. https:\/\/pubmed.ncbi.nlm.nih.gov\/30511641","DOI":"10.7554\/eLife.39023"},{"key":"794_CR74","doi-asserted-by":"publisher","unstructured":"\u00c7aku A, Seidah NG, Lortie A, Gagn\u00e9 N, Perron P, Dub\u00e9 J et al (2017) New insights of altered lipid profile in Fragile X Syndrome. PLoS ONE 12(3). https:\/\/doi.org\/10.1371\/journal.pone.0174301","DOI":"10.1371\/journal.pone.0174301"},{"key":"794_CR75","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-022-07064-z","volume":"12","author":"A Toupin","year":"2022","unstructured":"Toupin A, Benachenhou S, Abolghasemi A, Laroui A (2022) Association of lipid rafts cholesterol with clinical profile in fragile X syndrome. Sci Rep 12:1\u20139. https:\/\/doi.org\/10.1038\/s41598-022-07064-z","journal-title":"Sci Rep"},{"key":"794_CR76","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.biochi.2016.09.002","volume":"130","author":"R Tabeta","year":"2016","unstructured":"Tabeta R, Vitaleb N, Moine H (2016) Fragile X syndrome: are signaling lipids the missing culprits? Biochimie 130:188\u2013194. https:\/\/doi.org\/10.1016\/j.biochi.2016.09.002","journal-title":"Biochimie"},{"key":"794_CR77","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.brainres.2012.06.056","volume":"1471","author":"AM Galvan","year":"2012","unstructured":"Galvan AM, Galvez R (2012) Neocortical vasculature abnormalities in the Fragile X mental retardation syndrome. Brain Res 1471:155\u2013161. https:\/\/doi.org\/10.1016\/j.brainres.2012.06.056","journal-title":"Brain Res"},{"issue":"11","key":"794_CR78","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1002\/dneu.22514","volume":"77","author":"AP Belagodu","year":"2017","unstructured":"Belagodu AP, Stephen F, Roberto G (2017) Neocortical developmental analysis of vasculature and their growth factors offer new insight into fragile X syndrome abnormalities. Dev Neurobiol 77(11):1321\u20131333. https:\/\/doi.org\/10.1002\/dneu.22514","journal-title":"Dev Neurobiol"},{"issue":"1","key":"794_CR79","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1002\/dneu.22404","volume":"77","author":"AP Belagodu","year":"2017","unstructured":"Belagodu AP, Zendeli L, Slater BJ, Galvez R (2017) Blocking elevated VEGF-Ab attenuates non-vasculature fragile X syndrome abnormalities. Dev Neurobiol 77(1):14\u201325. https:\/\/doi.org\/10.1002\/dneu.22404","journal-title":"Dev Neurobiol"},{"key":"794_CR80","unstructured":"National Fragile X Foundation (2020) Genetic Testing for Fragile X Syndrome and Associated Disorders. https:\/\/fragilex.org\/understanding-fragile-x\/fragile-x-101\/testing-diagnosis\/"},{"issue":"4","key":"794_CR81","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1080\/14737159.2020.1729744","volume":"20","author":"D Kumari","year":"2020","unstructured":"Kumari D, Usdin K (2020) Molecular analysis of FMR1 alleles for fragile X syndrome diagnosis and patient stratification. Expert Rev Mol Diagn 20(4):363\u2013365. https:\/\/doi.org\/10.1080\/14737159.2020.1729744","journal-title":"Expert Rev Mol Diagn"},{"issue":"5","key":"794_CR82","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1111\/bcpt.12938","volume":"122","author":"M Saiz-Rodr\u00edguez","year":"2018","unstructured":"Saiz-Rodr\u00edguez M, Belmonte C, Rom\u00e1n M, Ochoa D, Koller D, Taleg\u00f3n M et al (2018) Effect of polymorphisms on the Pharmacokinetics, Pharmacodynamics and Safety of Sertraline in healthy volunteers. Basic Clin Pharmacol Toxicol 122(5):501\u2013511. https:\/\/doi.org\/10.1111\/bcpt.12938","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"8","key":"794_CR83","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1097\/DBP.0000000000000334","volume":"37","author":"L Greiss Hess","year":"2016","unstructured":"Greiss Hess L, Fitzpatrick SE, Nguyen DV, Chen Y, Gaul KN, Schneider A et al (2016) A Randomized, Double-Blind, placebo-controlled trial of low-dose sertraline in Young Children with Fragile X Syndrome. J Dev Behav Pediatr 37(8):619\u2013628","journal-title":"J Dev Behav Pediatr"},{"key":"794_CR84","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1146\/annurev-med-081117-041238","volume":"70","author":"I Gantois","year":"2019","unstructured":"Gantois I, Popic J, Khoutorsky A, Sonenberg N (2019) Metformin for treatment of Fragile X Syndrome and Other Neurological disorders. Annu Rev Med 70:1\u201315","journal-title":"Annu Rev Med"},{"issue":"2","key":"794_CR85","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1111\/cge.13039","volume":"93","author":"ABC Dy","year":"2018","unstructured":"Dy ABC, Tassone F, Eldeeb M, Salcedo-Arellano MJ, Tartaglia N, Hagerman R (2018) Metformin as targeted treatment in fragile X syndrome. Clin Genet 93(2):216\u2013222","journal-title":"Clin Genet"},{"key":"794_CR86","doi-asserted-by":"publisher","unstructured":"Rosvall A, Biag HMB, Potter LA (2019) Metformin treatment in young children with fragile X syndrome. Mol Genet Genomic Med 7(6). https:\/\/doi.org\/10.1002\/mgg3.631","DOI":"10.1002\/mgg3.631"},{"issue":"1","key":"794_CR87","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1089\/can.2018.0053","volume":"4","author":"N Tartaglia","year":"2019","unstructured":"Tartaglia N, Bonn-Miller M, Hagerman R (2019) Treatment of Fragile X syndrome with Cannabidiol: a Case Series study and brief review of the literature. Cannabis Cannabinoid Res 4(1):3\u20139","journal-title":"Cannabis Cannabinoid Res"},{"key":"794_CR88","doi-asserted-by":"publisher","first-page":"762967","DOI":"10.3389\/fpsyt.2021.762967","volume":"12","author":"C Champigny","year":"2021","unstructured":"Champigny C, Morin-Parent F, Bellehumeur-Lefebvre L, \u00c7aku A, Lepage J-F, Corbin F (2021) Combining lovastatin and minocycline for the treatment of Fragile X Syndrome: results from the LovaMiX Clinical Trial. Front Psychiatry 12:762967","journal-title":"Front Psychiatry"},{"issue":"1","key":"794_CR89","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s11689-020-09315-4","volume":"12","author":"AJ Thurman","year":"2020","unstructured":"Thurman AJ, Potter LA, Kim K, Tassone F, Banasik A, Potter SN et al (2020) Controlled trial of lovastatin combined with an open-label treatment of a parent-implemented language intervention in youth with fragile X syndrome. J Neurodev Disord 12(1):12. https:\/\/doi.org\/10.1186\/s11689-020-09315-4","journal-title":"J Neurodev Disord"}],"container-title":["Neurogenetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10048-024-00794-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10048-024-00794-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10048-024-00794-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T04:05:25Z","timestamp":1769400325000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10048-024-00794-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,25]]},"references-count":89,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["794"],"URL":"https:\/\/doi.org\/10.1007\/s10048-024-00794-4","relation":{},"ISSN":["1364-6753"],"issn-type":[{"value":"1364-6753","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,25]]},"assertion":[{"value":"5 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"In the preparation of this manuscript, artificial intelligence tools were utilized exclusively for tasks such as language refinement and grammar checks, while ensuring that all scientific analysis, interpretation, and conclusions remain the work of the authors.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declaration of AI utilization"}}],"article-number":"6"}}